| Literature DB >> 25191508 |
Yuta Yoshino1, Yuki Ozaki2, Koichiro Kawasoe1, Shinichiro Ochi1, Takanori Niiya1, Naomi Sonobe1, Teruhisa Matsumoto1, Shu-Ichi Ueno1.
Abstract
Clozapine is well-known for successful use in schizophrenic patients treatment resistant to other antipsychotics. However, even with clozapine, 25% of schizophrenic patients are not in remission. Recently, as adjunctive treatment with clozapine, electroconvulsive therapy has been reported to be an effective and safe adjunctive treatment. We report a Japanese schizophrenic woman who was not in remission with clozapine alone but with both clozapine and electroconvulsive therapy.Entities:
Keywords: Clozapine; Electroconvulsive therapy; Lithium; Schizophrenia
Year: 2014 PMID: 25191508 PMCID: PMC4153864 DOI: 10.9758/cpn.2014.12.2.160
Source DB: PubMed Journal: Clin Psychopharmacol Neurosci ISSN: 1738-1088 Impact factor: 2.582